Results

Total Results: 266 records

Showing results for "percent".

1. Archived: Evidence Summary: Depression: Screening 2002 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/depression-screening-2002
   May 07, 2002 - vs. 8 percent; difference, 17 percent; CI, 3 percent to 32 percent). … vs. 27 percent; difference, 11 percent; CI, -8 percent to 29 percent). … vs. 74 percent; difference, 5 percent; CI, -14 percent to 3 percent). … ; 95 percent CI, -61 percent to -3 percent). … vs. 32 percent; difference, 50 percent; CI, 41 percent to 58 percent).

2. Archived: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-children-and-adolescents-screening-2009
   March 15, 2009 - to 100 percent (BDI ≥11) or 77 percent to 100 percent (BDI ≥16) and specificity ranging from 77 percent … to 86 percent (BDI ≥11) or 65 percent to 96 percent (BDI ≥16). … to 100 percent and specificity ranged from 38 percent to 97 percent). … (95 percent confidence interval [CI]: 7 percent-16 percent). … (95 percent CI: 2.8-3.1) in the 5- to 14-year age group compared with 1.4 percent (95 percent CI: 1.3

3. Archived: Final Evidence Review: Syphilis Infection: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review93/syphilis-infection-screening-2004
   July 15, 2004 - to 86 percent in primary syphilis, 100 percent during secondary syphilis, and 95 percent to 98 percent … from 64.3 percent to 90.0 percent. … and 93 percent compared to TPHA, and 99.4 percent and 100 percent compared to the FTA-ABS test. … sensitive and 94.1 percent specific; the RST was 75 percent sensitive and 95.2 percent specific. … to 89 percent in live-born infants, and from 91 percent to 97 percent in stillborn fetuses.

4. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
   March 15, 2005 - of 97 percent for HSV-1 and 100 percent for HSV-2. … 1 and 42 percent (95% CI, 31 percent to 74 percent) for women patients in study 2. … In study 2, the efficacy for women was 74 percent (95% CI, 9 percent to 93 percent; P = 0.02). … Overall vaccine efficacy was 9 percent (95% CI, -29 percent to 36 percent). … with 18 percent to 37 percent in historical controls).

5. Archived: Prostate Cancer: Screening, 2002 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2002
   December 01, 2002 - 2.01 percent for men aged 50, and 6.46 percent for men aged 60. 5 The burden of prostate cancer varies … only a 3 percent lifetime risk of dying from the disease. 5  More than 75 percent of all cases of prostate … vs 8.9 percent) and of developing distant metastases (13.4 percent vs 27.3 percent) after 8 years for … vs 28 percent). … vs 45 percent) and urinary leakage (49 percent vs 21 percent) than patients receiving watchful waiting

6. Archived: Final Evidence Summary: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary21/depression-in-children-and-adolescents-screening-2009
   March 15, 2009 - Sensitivity ranged from 18 percent to 100 percent, and specificity ranged from 38 percent to 97 percent … values of 56 percent for both tests and negative predictive values of 97 percent to 99 percent in these … or 2 percent. … 91 percent and specificities of 91 percent and 94 percent in instruments developed for primary care … 8-17 219 9 ≥30 percent decrease in CDRS-R 71/109 (65 percent) 54/101 (54 percent) 12 (

7. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
   January 15, 2002 - Fewer than 1 percent of participants were lost to followup in BMD, PHS, and TPT, and 2.6 percent were … percent in BMD and TPT. … percent. … ; PHS, 2 percent; BMD, 2 percent; TPT, 2 percent). … percent per year for CHD.

8. Archived: Final Evidence Review: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
   May 15, 2004 - Five-year relative survival rates for women with regional and distant disease are 79 percent and 28 percent … , with a false-positive result rate of approximately 1.2 percent to 2.5 percent based on 5 studies. 20 … CA 125-based multimodal screening was estimated at 80 percent, with false-positive rates of 0.1 percent … screening was estimated as 1 percent for initial recall and 15 percent for surgery. … using annual CA 125 (assuming 3 percent recall and 0.2 percent false-positive results).

9. Archived: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-virus-infection-screening-2004
   March 08, 2004 - In a population with a low prevalence of HCV infection (e.g., 2 percent), approximately 59 percent of … In 4 studies reviewed, third-generation EIA had a sensitivity ranging from 94 percent to 100 percent … In populations with a low prevalence of HCV infection (2 percent), approximately 59 percent of all … for those at average risk and 50 percent to 90 percent for those at high risk. … withdrawal from combination therapy ranged from 10 percent to 20 percent. 2 The most common adverse

10. Archived: Addendum to Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement: Ovarian Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
    April 15, 2012 - While 5-year survival from ovarian cancer is 94 percent when identified at the local stage, only 15 percent … only 28 percent. … Repeat testing was required for 9.1 percent of women in the MMS group (or 8.7 percent; article contained … and 1.8 percent in the USS group. … In particular, serous tumors comprised about 31 percent of cases in the screened group and 50 percent

11. Archived: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening-february-2005
    February 15, 2005 - Ultrasonography has a sensitivity of 95 percent and specificity of nearly 100 percent when performed … to 9 percent in men and 1 percent in women. 7-12 The prevalence of an AAA greater than 5.0 cm in men … The study showed AAA related-mortality was reduced by an average of 42 percent (95 percent CI, 22 percent … in AAA-specific mortality was 0.14 percent (0.33 percent in the non-screened group and 0.19 percent … and conversion to open repair at an annual rate of 2 percent, with a 24-percent peri-operative mortality

12. Addendum to Screening for Ovarian Cancer: Evidence Update for the USPSTF Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
    December 31, 2014 - is only 28 percent. … Repeat testing was required for 9.1 percent of women in the MMS group (or 8.7 percent; article contained … Overall, 1.0 percent of women underwent surgery, and 2.9 percent of women who had surgery but not cancer … percent for screen-detected cancer) compared with the control group (38 percent). … In particular, serous tumors comprised about 31 percent of cases in the screened group and 50 percent

13. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - Hospital study 6 and 0.87 (95 percent CI, 0.62-2.14) for the Italian Tamoxifen Prevention Study.[[8 … ; 95 percent CI, 1.12-11.15). … vs 28.7 percent in the placebo group) and bothersome vaginal discharge (12.4 percent in the tamoxifen … group vs 4.5 percent in the placebo group). 7  Women given raloxifene also noted higher rates of hot … flashes than women given placebo (10.7 percent in the ralixifene group vs 6.4 percent in the placebo

14. Archived: Syphilis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-screening-2004
    July 15, 2004 - to 12.2 percent in incarcerated women and 0.9 percent to 5.2 percent in incarcerated men. 4 Commercial … syphilis infection, 100 percent for detecting secondary syphilis infection, and 95 percent to 98 percent … Specificity ranges from 85 percent to 99 percent and may be reduced in individuals who have preexisting … and specificity of 95 percent, and FTA-ABS sensitivity of 92 percent and specificity of 96 percent), … , an RPR sensitivity of 91 percent and specificity of 95 percent, and FTA-ABS sensitivity of 92 percent

15. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - to 84 percent for breast cancer and 10 percent to 50 percent for ovarian cancer. … to 84 percent for breast cancer and 10 percent to 50 percent for ovarian cancer, calculated to age 70 … ), moderate risk (10 percent to 25 percent), and high risk (>25 percent). … , 9 percent; specificity, 99.3 percent). … to 100 percent and reduced breast cancer risk by 53 percent to 68 percent.

16. Archived: Final Evidence Review: Ovarian Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
    April 15, 2012 - The positive predictive value (PPV) of TVU was 1.6 percent for any neoplasm, and 1.0 percent if tumors … The PPV of CA-125 testing was 4.0 percent for any neoplasm, and 3.7 percent for invasive cancer only. … The PPV for the combined tests was 26.5 percent for any neoplasm and 23.5 percent for invasive cancer … TVU was abnormal in 23 (7.9 percent) women and CA-125 tests were abnormal (>35 U/mL) in 13 (4.5 percent … Only three women (representing 8 percent of women with an abnormal test result, or 1 percent of the 290

17. Archived: Visual Impairment in Children Ages 1-5: Screening, 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/visual-impairment-in-children-ages-1-5-screening-2004
    January 14, 2004 - to 10 percent of all preschoolers. … Amblyopia is present in 1 percent to 4 percent of preschool children; an estimated 5 percent to 7 percent … vs 1.8 percent) and a lower prevalence of residual amblyopia after treatment (7.5 percent vs 25 percent … to 71 percent and a specificity of 70 percent to 80 percent. 6 A good quality systematic review, evaluating … Sensitivity ranged from 37 percent to 88 percent, and specificity ranged from 40 percent to 88 percent

18. Archived: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2004
    May 04, 2004 - (i.e., 98 percent of women with positive test results will not have ovarian cancer). … woman without a family history of ovarian cancer to about 5 percent if she has 1 relative and 7 percent … Two large cohort studies using transvaginal ultrasound screening reported that 59 percent to 65 percent … high risk for ovarian cancer, the sensitivity would be reduced to 50 percent. … interval [CI], 47%-100%); and the specificity is estimated to range from 97 percent to 99 percent. 15

19. Archived: Osteoporosis: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2002
    September 17, 2002 - who will develop a vertebral deformity 6 and 15 percent who will suffer a hip fracture. 7 Risk for … for the hip, 9 percent for distal forearm, and 5 percent for proximal humerus.9 Sixteen percent of postmenopausal … and specificity of 41 percent. 4 The SCORE has a sensitivity of 91 percent and specificity of 40 percent … fracture (18.2 percent vs. 13.6 percent; RH, 0.72 [0.58-0.90]). … to 13.1 percent (RR, 0.64; 0.50-0.82).

20. Screening for Ovarian Cancer: Evidence Update for the USPTF Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/fNXdu3HGvWE-ovsuhNeANW
    April 01, 2012 - The positive predictive value (PPV) of TVU was 1.6 percent for any neoplasm, and 1.0 percent if tumors … The PPV of CA- 125 testing was 4.0 percent for any neoplasm, and 3.7 percent for invasive cancer only … The PPV for the combined tests was 26.5 percent for any neoplasm and 23.5 percent for invasive cancer … TVU was abnormal in 23 (7.9 percent) women and CA-125 tests were abnormal (>35 U/mL) in 13 (4.5 percent … Only three women (representing 8 percent of women with an abnormal test result, or 1 percent of the